Erlonat 150 mg (Erlotinib) Quantity:90 Tablet/s Dosage of Endoxan 50 mg

Dosage of Endoxan 50 mg is highly individualized and depends on the indication

Sildalist 120mg provides unique physiological benefits due to the careful strategic synchronization of its dual active compounds

Donepezil exerts its therapeutic effect by selectively inhibiting the enzyme acetylcholinesterase

Separate from antacids by at least 4 hours

Ifin 500 mg is indicated for the treatment of various superficial and systemic fungal infections

Erlonat 150 mg (Erlotinib) Quantity:90 Tablet/s Dosage of Endoxan 50 mg\nErlonat 150 mg (Erlotinib) \nManufacturer: Natco Pharma Ltd. Strength: 150 mg Packaging: 30 tablets per bottle \n\nProduct Overview \nErlonat is an oral, targeted anticancer agent that contains the active pharmaceutical ingredient erlotinib. It is formulated as filmcoated tablets, each delivering 150 mg of the compound, and is supplied in a bottle containing 30 tablets. The product is indicated for the treatment of advanced nonsmall cell lung cancer